The Vertical Group — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Route 92 Medicalr92m.com in 𝕏Jul 2024 · $31M✓ verified

Route 92 Medical develops neurointervention catheter systems and devices aimed at improving outcomes for neurovascular patients, including stroke treatment.

BiotechHardwareHealthtechMedical DevicesSan Mateo, US

Dr. Chou(Founder & Chief Executive Officer)Cindy Lynch(Executive Officer)inDr. Joey English(Chief Medical Officer)Tony Chou(Founder)in

BoardJack Lasersohn(Director)inTamir Meiri(Director)

Board seatJack W. Lasersohn· per SEC Form D

Co-investorsNovo Holdings Norwest Venture Partners Runway Growth Capital US Venture Partners Sectoral Asset Management Sofinnova Ventures +1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.